Researchers Develop Prognostic Model for Survival in Patients With MF Undergoing Allo-HCT
In addition to current available risk scores, the new system can help counsel patients with myelofibrosis (MF) undergoing allogeneic hematopoietic stem cell transplantation (allo-HCT), authors wrote.
United States Marrow Transplant Research United States The Center Dynamic International Prognostic European Bone Marrow Transplant Allo Hct
Source: ajmc.com